Life Healthcare seals deal on cancer-screening tool
Life Healthcare's subsidiary, Life Molecular Imaging, has sub-licensed its radiotherapeutic products to Lantheus Holdings for $35 million.
Life Healthcare's subsidiary, Life Molecular Imaging, has sub-licensed its radiotherapeutic products to Lantheus Holdings for $35 million.
India will incentivise local GLP-1 drug manufacturing by 2026, targeting diabetes and obesity treatments, as Novo Nordisk's patent expires.